Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A''DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines

Author：      

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.2, Iss.3, 2011-01, pp. : 523-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer cell lines lack amplification: Overexpression of HER2

By Ullén Anders   Lennartsson Lena   Harmenberg Ulrika   Lennernäs Bo   Majumder Khairul   Holmberg Anders   Nilsson Sten   Elmberger Göran  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 490-495

Informa Healthcare

Access to resources Recommend Favorite

Molecular Profiling in Prostate Cancer

By Feroze-Merzoug F.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

In vitro modeling of HER2-targeting therapy in disseminated prostate cancer

By          

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2153-2158

Spandidos Publications

Access to resources Recommend Favorite

Comparative evaluation of 111In-labeled NOTAconjugated affibody molecules for visualization of HER3 expression in malignant tumors

By                  

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 1042-1048

Spandidos Publications

Access to resources Recommend Favorite

Molecular and cellular biology of prostate cancer

By Lalani E-N.  

Cancer and Metastasis Reviews, Vol. 16, Iss. 1-2, 1997-06 ,pp. : 29-66

Springer Publishing Company

Access to resources Recommend Favorite